Background Community-acquired pneumonia (CAP) causes a large burden of disease. Due
to difficulties in obtaining representative respiratory samples and insensitive standard …

Background Rapid and accurate detection of pathogens is needed in community-acquired
pneumonia (CAP) to enable appropriate antibiotics and to slow the development of antibiotic …

Background. The frequent lack of a microbiological diagnosis in community-acquired
pneumonia (CAP) impairs pathogen-directed antimicrobial therapy. This study assessed the …

Lack of rapid and comprehensive microbiological diagnosis in patients with community
acquired pneumonia (CAP) hampers appropriate antimicrobial therapy. This study evaluates …

Objectives The usefulness of routine microbiological testing for rationalising antibiotic use in
hospitalised patients with community-acquired pneumonia (CAP) continues to be a subject …

Importance Lower respiratory tract (LRT) infections, including community-acquired
pneumonia (CAP), are a leading cause of hospital admissions and mortality. Molecular tests …

Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality
worldwide [1]. Despite advances in antibiotic treatment and medical care, the mortality of …

Background Despite recent advances in microbiological techniques, the etiology of
community-acquired pneumonia (CAP) is still not well described. We applied polymerase …

Community Acquired Pneumonia (CAP) is a frequent and potentially fatal infectious disease
which, in the majority of cases, needs an antibiotic intervention. OBJECTIVES: Aim was to …

Purpose Studies on aetiology of community-acquired pneumonia (CAP) vary in terms of
microbial sampling methods, anatomical locations, and laboratory analyses, since no gold …